Abstract:With the development of high-throughput technology and the accumulation of biomedical data, the prior information of biological entity can be calculated from different aspects. Specifically, drug-drug similarities can be measured from target profiles, drug-drug interaction and side effects. Similarly, different methods and data sources to calculate disease ontology can result in multiple measures of pairwise disease similarities. Therefore, in computational drug repositioning, developing a dynamic method to optimize the fusion process of multiple similarities is a crucial and challenging task. In this study, we propose a multi-similarities bilinear matrix factorization (MSBMF) method to predict promising drug-associated indications for existing and novel drugs. Instead of fusing multiple similarities into a single similarity matrix, we concatenate these similarity matrices of drug and disease, respectively. Applying matrix factorization methods, we decompose the drug-disease association matrix into a drug-feature matrix and a disease-feature matrix. At the same time, using these feature matrices as basis, we extract effective latent features representing the drug and disease similarity matrices to infer missing drug-disease associations. Moreover, these two factored matrices are constrained by non-negative factorization to ensure that the completed drug-disease association matrix is biologically interpretable. In addition, we numerically solve the MSBMF model by an efficient alternating direction method of multipliers algorithm. The computational experiment results show that MSBMF obtains higher prediction accuracy than the state-of-the-art drug repositioning methods in cross-validation experiments. Case studies also demonstrate the effectiveness of our proposed method in practical applications. Availability: The data and code of MSBMF are freely available at https://github.com/BioinformaticsCSU/MSBMF. Corresponding author: Jianxin Wang, School of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, P. R. China. E-mail: jxwang@mail.csu.edu.cn Supplementary Data: Supplementary data are available online at https://academic.oup.com/bib.

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review

A Pathway Profile-Based Method for Drug Repositioning

Machine learning for drug repositioning: Recent advances and challenges

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Machine Learning and Deep Learning Strategies in Drug Repositioning

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

DDAPRED: a Computational Method for Predicting Drug Repositioning Using Regularized Logistic Matrix Factorization

Link Prediction Only with Interaction Data and Its Application on Drug Repositioning

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

A Hybrid Neural Collaborative Filtering Model for Drug Repositioning

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

A Review of Recent Developments and Progress in Computational Drug Repositioning.

Computational drug repositioning: from data to therapeutics.

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.